Callum McKeefery

He's got a super rare disease.

We know a lot about it.

I actually fund a research lab in Buffalo, and I'm funding a lot of research, actually doing something with Harvard at the moment on mitochondrial transplants, which is amazing, amazing potential with that.

And we've just got him access to a new drug, which is he's the first kid in the world to get access to this drug.

Rare disease, life expectancies...

Very hit and miss.

50 kids.

We lost about 10 during COVID.

And after COVID coming out and being so close to those families who lost children, I was like, Jesus, you know, I wanted to add some security to him.

It's probably never going to work.

So I wanted to add some security to him.

I wanted to do more research.

I wanted to fund some more research for him.

And that was a big driver for doing the sale.

I absolutely love the reviews business and I loved working with my team.

And if it wasn't, you know, things happen for a reason and maybe, you know, it was the right time.

You know, looking back, we'll look back through the lens of history and it will go, wow, look at the timing there.

But the timing really...

I did the deal because of, I wanted to add security to my family and, you know, fund some research, go and get some cures for these kids.

And we are doing it.